NCT02791191

Who might be able to join this trial:

• A qualified doctor has diagnosed you with mild Alzheimer's disease dementia based on recognised medical guidelines.
• You scored between 20 and 26 (inclusive) on a standard memory and thinking test called the Mini-Mental State Examination at your screening appointment.
• A special brain scan (called a florbetapir PET scan) showed signs of a protein buildup in the brain linked to Alzheimer's disease.

Who may not be able to join:

• You have a significant brain or nervous system condition other than Alzheimer's, such as another type of dementia, a serious brain infection, Parkinson's disease, multiple concussions, or epilepsy or repeated seizures (childhood febrile seizures may be an exception — confirm with trial site).
• You have an eye condition that would make it difficult to reliably test your vision or examine the back of your eye.
• You are currently taking certain strong medications that affect how the body breaks down drugs through a liver enzyme called CYP3A (confirm with trial site which medications apply).
• You have a known sensitivity or allergic reaction to florbetapir or a related substance called ¹⁸F-AV-1451, which are used in the brain scans.
• You are unable to have an MRI or PET scan, or you have very difficult-to-access veins for blood tests.

Important: Always verify eligibility with the trial site directly before applying.